David P. Kerstein
2022
In 2022, David P. Kerstein earned a total compensation of $1.8M as Chief Medical Officer at Theseus Pharmaceuticals, a 72% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $186,000 |
|---|---|
| Option Awards | $1,150,350 |
| Salary | $465,000 |
| Other | $16,790 |
| Total | $1,818,140 |
Kerstein received $1.2M in option awards, accounting for 63% of the total pay in 2022.
Kerstein also received $186K in non-equity incentive plan, $465K in salary and $16.8K in other compensation.
Rankings
In 2022, David P. Kerstein's compensation ranked 1,913th out of 5,756 executives tracked by ExecPay. In other words, Kerstein earned more than 66.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,913 out of 5,756 | 67th |
Division Manufacturing | 1,016 out of 3,133 | 68th |
Major group Chemicals And Allied Products | 429 out of 1,419 | 70th |
Industry group Drugs | 394 out of 1,320 | 70th |
Industry Pharmaceutical Preparations | 284 out of 966 | 71st |
Source: SEC filing on April 26, 2023.
Kerstein's colleagues
We found two more compensation records of executives who worked with David P. Kerstein at Theseus Pharmaceuticals in 2022.